The effectiveness of last season's COVID vaccines among immunocompetent adults reached 40% against hospitalization and 79% ...

Drug discovery requires two separate steps: checking whether a drug can bind to a harmful molecule or its receptor, and ...

Scientists are closely watching SARS-CoV-2 to track mutations and see if it's developed into different strains. So, has it?

Scientists investigating the mysteries of SARS-CoV-2 are finding subtle differences in brain structure among babies exposed to the virus before they were born. They say their findings underscore the ...

A growing body of research suggests that everything from the shape of your lungs to how you enunciate your Ts and Ks could make you a flu superspreader.

A 10-second act of kindness on a flight linked an Indian scientist with an elderly Japanese couple, creating an unexpected family bond that crossed borders, cultures and years.

A multi-country study of 3,157 Long COVID patients found neurological and mental health symptoms were reported far more ...

Two little-known animal-origin pathogens are quietly adapting in humans. Scientists warn that weak surveillance, evolving strains, and limited immunity could set the stage for a future global health ...

The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients experiencing the same infection.

From projects examining healthcare initiative impacts to groundbreaking medical developments, the forum — which annually ...

We are our own worst enemy When, oh when, is the American medical community going to accept the reality that this country’s biggest healthcare problem isn’t insurance or medications; ...

The mpox virus appears to be circulating silently in parts of Nigeria, in many cases without the symptoms typically associated with the disease, according to new research led by scientists from the ...